DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs

Conditions: Lung Cancer Interventions: Drug: LG002 Sponsors: Zhen-Yu Ding Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials